[Problems in general management during barbiturate therapy].

Area of Science:

• Neurology
• Critical Care Medicine
• Pharmacology

Context:

• Investigates the safety and efficacy of barbiturate regimens in managing severe neurological conditions.
• Focuses on patients with severe head injury or cerebrovascular disease requiring intensive treatment.
• Examines complications associated with intravenous barbiturate administration at 1-4 mg/kg/hr.

Purpose:

• To analyze immediate and delayed complications arising from barbiturate therapy.
• To identify the incidence and nature of adverse events associated with barbiturate use.
• To inform clinical practice regarding the safe administration of barbiturates.

Summary:

• Barbiturate therapy in 63 patients with severe head injury or cerebrovascular disease revealed immediate complications: tachycardia (25%) and hypotension (22%), more frequent in surgical patients.
• Delayed complications were common, including hypokalemia (65%), liver dysfunction (38%), infection (33%), cardiac failure (13%), and renal failure (2%).
• Supportive treatments like dobutamine and dopamine were used to prevent cardiac and renal failure during barbiturate regimens.

Impact:

• Highlights the significant risk of both immediate and delayed adverse events during barbiturate therapy.
• Emphasizes the need for vigilant monitoring and proactive management strategies to mitigate barbiturate-induced complications.
• Provides critical data for clinicians considering barbiturate regimens in neurocritical care settings.